Title: [1,2,4]triazol-3-ylsulfanylmethyl)-3-phenyl-[1,2,4]oxadiazoles: antagonists of the Wnt pathway that inhibit tankyrases 1 and 2 via novel adenosine pocket binding.
Journal: Journal of medicinal chemistry 20120209
863405-60-1
313951-59-6 | L-Arginine,glycyl-L-seryl-L-seryl-L-phenylalanyl-L-leucyl-L-seryl-L-prolyl-L-a-glutamyl-L-histidyl-L-glutaminyl-L-arginyl-L-valyl-L-glutaminyl-L-glutaminyl-L-arginyl-L-lysyl-L-a-glutamyl-L-seryl-L-lysyl-L-lysyl-L-prolyl-L-prolyl-L-alanyl-L-lysyl-L-leucyl-L-glutaminyl-L-prolyl- | AA01ENN4 | MFCD08460342
2115701-93-2 | (+)-JQ1 PA | AA01ENU7 | MFCD31715451
70363-83-6 | DiBAC4(3) | AA01EO1K | MFCD00467633
1621999-82-3 | CC-90003 | AA01EO4L | MFCD31692404
2055536-64-4 | LYC-55716 | AA01EO9X | MFCD31544352
1464151-33-4 | ETC-206 | AA01EOFX | MFCD31692387
701977-00-6 | Taranabant racemate | AA01EOKP | MFCD16036070
2095551-10-1 | Sofosbuvir impurity M | AA01EOQ0 | MFCD28387167
1934-55-0 | 1-phenyl-N-propyl-cyclohexanamine,monohydrochloride | AA01EOZ7
2097130-87-3 | 9S-[(1-oxohexadecyl)oxy]-octadecanoicacid | AA01EPAI